Natco Pharma's Kothur-JR Unit Receives 7 FDA Observations—Inspection Wraps Up, Compliance Under the Limelight

Unknown Apr 02, 2026 900 Views

Natco Pharma Ltd. has informed that the US FDA inspection of its Kothur-JR manufacturing facility, conducted from June 9 through June 19, 2025, is completed. The inspection resulted in the generation of seven observations in Form 483, which is a set of areas where the company's procedures are...